tiprankstipranks
Trending News
More News >
Vanda Sets 2025 Executive Compensation Plans
PremiumCompany AnnouncementsVanda Sets 2025 Executive Compensation Plans
2M ago
Vanda Pharmaceuticals: Promising Revenue Growth and Strategic Pipeline Drive Buy Rating
Premium
Ratings
Vanda Pharmaceuticals: Promising Revenue Growth and Strategic Pipeline Drive Buy Rating
2M ago
Vanda Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
Premium
The Fly
Vanda Pharmaceuticals price target raised to $20 from $18 at H.C. Wainwright
2M ago
Vanda Pharmaceuticals reports Q EPS (8c) vs. (4c) last year
PremiumThe FlyVanda Pharmaceuticals reports Q EPS (8c) vs. (4c) last year
2M ago
Vanda’s Strategic In-Licensing of Imsidolimab Signals Promising Growth in GPP Market
Premium
Ratings
Vanda’s Strategic In-Licensing of Imsidolimab Signals Promising Growth in GPP Market
3M ago
AnaptysBio, Vanda announce exclusive global license agreement for Vanda
Premium
The Fly
AnaptysBio, Vanda announce exclusive global license agreement for Vanda
3M ago
Vanda Pharmaceuticals issues letter to FDA on faulty gastroparesis NDA review
PremiumThe FlyVanda Pharmaceuticals issues letter to FDA on faulty gastroparesis NDA review
4M ago
Vanda Pharmaceuticals: Orphan Drug Designation Granted for VGT-1849A
Premium
The Fly
Vanda Pharmaceuticals: Orphan Drug Designation Granted for VGT-1849A
4M ago
Vanda Pharmaceuticals treatment of polycythemia vera granted orphan status
Premium
The Fly
Vanda Pharmaceuticals treatment of polycythemia vera granted orphan status
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100